Response surface model for anesthetic drug interactions

Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response rela...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anesthesiology (Philadelphia) 2000-06, Vol.92 (6), p.1603-1616
Hauptverfasser: MINTO, C. F, SCHNIDER, T. W, SHORT, T. G, GREGG, K. M, GENTILINI, A, SHAFER, S. L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1616
container_issue 6
container_start_page 1603
container_title Anesthesiology (Philadelphia)
container_volume 92
creator MINTO, C. F
SCHNIDER, T. W
SHORT, T. G
GREGG, K. M
GENTILINI, A
SHAFER, S. L
description Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response relation between combinations of anesthetic drugs and is mathematically consistent with models of the concentration-response relation of single drugs. The authors defined a parameter, theta, that describes the concentration ratio of two potentially interacting drugs. The classic sigmoid Emax model was extended by making the model parameters dependent on theta. A computer program was used to estimate response surfaces for the hypnotic interaction between midazolam, propofol, and alfentanil, based on previously published data. The predicted time course of effect was simulated after maximally synergistic bolus dose combinations. The parameters of the response surface were identifiable. With the test data, each of the paired combinations showed significant synergy. Computer simulations based on interactions at the effect site predicted that the maximally synergistic three-drug combination tripled the duration of effect compared with propofol alone. Response surfaces can describe anesthetic interactions, even those between agonists, partial agonists, competitive antagonists, and inverse agonists. Application of response-surface methodology permits characterization of the full concentration-response relation and therefore can be used to develop practical guidelines for optimal drug dosing.
doi_str_mv 10.1097/00000542-200006000-00017
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00000542_200006000_00017</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10839909</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-7fe87becf741a6ad1ad441812fabb3b2713e9a41ef9d6ac2500b984f0896e7a63</originalsourceid><addsrcrecordid>eNpNkE1LAzEQhoMotlb_guTgNZpJdjfJUYpWoSCInpfZ7ERX2t2SbA_-e1NbPwaG-eB5B-ZljIO8BunMjdxFWSihdk2VU-QEc8SmUCorAEx5zKZ5p4WWSk3YWUofeTSltqdsAtJq56SbMvNMaTP0iXjaxoCe-HpoacXDEDn2lMZ3GjvP27h9410_UkQ_dpk_ZycBV4kuDnXGXu_vXuYPYvm0eJzfLoXXTo7CBLKmIR9MAVhhC9gWBVhQAZtGN8qAJocFUHBthV6VUjbOFkFaV5HBSs-Y3d_1cUgpUqg3sVtj_KxB1jsv6h8v6l8v6m8vsvRyL91smzW1_4T75zNwdQAweVyFiL3v0h-nnbXO6C-yXmak</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Response surface model for anesthetic drug interactions</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>MINTO, C. F ; SCHNIDER, T. W ; SHORT, T. G ; GREGG, K. M ; GENTILINI, A ; SHAFER, S. L</creator><creatorcontrib>MINTO, C. F ; SCHNIDER, T. W ; SHORT, T. G ; GREGG, K. M ; GENTILINI, A ; SHAFER, S. L</creatorcontrib><description>Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response relation between combinations of anesthetic drugs and is mathematically consistent with models of the concentration-response relation of single drugs. The authors defined a parameter, theta, that describes the concentration ratio of two potentially interacting drugs. The classic sigmoid Emax model was extended by making the model parameters dependent on theta. A computer program was used to estimate response surfaces for the hypnotic interaction between midazolam, propofol, and alfentanil, based on previously published data. The predicted time course of effect was simulated after maximally synergistic bolus dose combinations. The parameters of the response surface were identifiable. With the test data, each of the paired combinations showed significant synergy. Computer simulations based on interactions at the effect site predicted that the maximally synergistic three-drug combination tripled the duration of effect compared with propofol alone. Response surfaces can describe anesthetic interactions, even those between agonists, partial agonists, competitive antagonists, and inverse agonists. Application of response-surface methodology permits characterization of the full concentration-response relation and therefore can be used to develop practical guidelines for optimal drug dosing.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/00000542-200006000-00017</identifier><identifier>PMID: 10839909</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Algorithms ; Anesthetics - pharmacokinetics ; Anesthetics - pharmacology ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Computer Simulation ; Dose-Response Relationship, Drug ; Drug Interactions ; Humans ; Medical sciences ; Models, Theoretical ; Neuropharmacology ; Pharmacology. Drug treatments</subject><ispartof>Anesthesiology (Philadelphia), 2000-06, Vol.92 (6), p.1603-1616</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-7fe87becf741a6ad1ad441812fabb3b2713e9a41ef9d6ac2500b984f0896e7a63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1398897$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10839909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MINTO, C. F</creatorcontrib><creatorcontrib>SCHNIDER, T. W</creatorcontrib><creatorcontrib>SHORT, T. G</creatorcontrib><creatorcontrib>GREGG, K. M</creatorcontrib><creatorcontrib>GENTILINI, A</creatorcontrib><creatorcontrib>SHAFER, S. L</creatorcontrib><title>Response surface model for anesthetic drug interactions</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response relation between combinations of anesthetic drugs and is mathematically consistent with models of the concentration-response relation of single drugs. The authors defined a parameter, theta, that describes the concentration ratio of two potentially interacting drugs. The classic sigmoid Emax model was extended by making the model parameters dependent on theta. A computer program was used to estimate response surfaces for the hypnotic interaction between midazolam, propofol, and alfentanil, based on previously published data. The predicted time course of effect was simulated after maximally synergistic bolus dose combinations. The parameters of the response surface were identifiable. With the test data, each of the paired combinations showed significant synergy. Computer simulations based on interactions at the effect site predicted that the maximally synergistic three-drug combination tripled the duration of effect compared with propofol alone. Response surfaces can describe anesthetic interactions, even those between agonists, partial agonists, competitive antagonists, and inverse agonists. Application of response-surface methodology permits characterization of the full concentration-response relation and therefore can be used to develop practical guidelines for optimal drug dosing.</description><subject>Algorithms</subject><subject>Anesthetics - pharmacokinetics</subject><subject>Anesthetics - pharmacology</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Computer Simulation</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Interactions</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Theoretical</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkE1LAzEQhoMotlb_guTgNZpJdjfJUYpWoSCInpfZ7ERX2t2SbA_-e1NbPwaG-eB5B-ZljIO8BunMjdxFWSihdk2VU-QEc8SmUCorAEx5zKZ5p4WWSk3YWUofeTSltqdsAtJq56SbMvNMaTP0iXjaxoCe-HpoacXDEDn2lMZ3GjvP27h9410_UkQ_dpk_ZycBV4kuDnXGXu_vXuYPYvm0eJzfLoXXTo7CBLKmIR9MAVhhC9gWBVhQAZtGN8qAJocFUHBthV6VUjbOFkFaV5HBSs-Y3d_1cUgpUqg3sVtj_KxB1jsv6h8v6l8v6m8vsvRyL91smzW1_4T75zNwdQAweVyFiL3v0h-nnbXO6C-yXmak</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>MINTO, C. F</creator><creator>SCHNIDER, T. W</creator><creator>SHORT, T. G</creator><creator>GREGG, K. M</creator><creator>GENTILINI, A</creator><creator>SHAFER, S. L</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20000601</creationdate><title>Response surface model for anesthetic drug interactions</title><author>MINTO, C. F ; SCHNIDER, T. W ; SHORT, T. G ; GREGG, K. M ; GENTILINI, A ; SHAFER, S. L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-7fe87becf741a6ad1ad441812fabb3b2713e9a41ef9d6ac2500b984f0896e7a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Algorithms</topic><topic>Anesthetics - pharmacokinetics</topic><topic>Anesthetics - pharmacology</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Computer Simulation</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Interactions</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Theoretical</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MINTO, C. F</creatorcontrib><creatorcontrib>SCHNIDER, T. W</creatorcontrib><creatorcontrib>SHORT, T. G</creatorcontrib><creatorcontrib>GREGG, K. M</creatorcontrib><creatorcontrib>GENTILINI, A</creatorcontrib><creatorcontrib>SHAFER, S. L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MINTO, C. F</au><au>SCHNIDER, T. W</au><au>SHORT, T. G</au><au>GREGG, K. M</au><au>GENTILINI, A</au><au>SHAFER, S. L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response surface model for anesthetic drug interactions</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>2000-06-01</date><risdate>2000</risdate><volume>92</volume><issue>6</issue><spage>1603</spage><epage>1616</epage><pages>1603-1616</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>Anesthetic drug interactions traditionally have been characterized using isobolographic analysis or multiple logistic regression. Both approaches have significant limitations. The authors propose a model based on response-surface methodology. This model can characterize the entire dose-response relation between combinations of anesthetic drugs and is mathematically consistent with models of the concentration-response relation of single drugs. The authors defined a parameter, theta, that describes the concentration ratio of two potentially interacting drugs. The classic sigmoid Emax model was extended by making the model parameters dependent on theta. A computer program was used to estimate response surfaces for the hypnotic interaction between midazolam, propofol, and alfentanil, based on previously published data. The predicted time course of effect was simulated after maximally synergistic bolus dose combinations. The parameters of the response surface were identifiable. With the test data, each of the paired combinations showed significant synergy. Computer simulations based on interactions at the effect site predicted that the maximally synergistic three-drug combination tripled the duration of effect compared with propofol alone. Response surfaces can describe anesthetic interactions, even those between agonists, partial agonists, competitive antagonists, and inverse agonists. Application of response-surface methodology permits characterization of the full concentration-response relation and therefore can be used to develop practical guidelines for optimal drug dosing.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>10839909</pmid><doi>10.1097/00000542-200006000-00017</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-3022
ispartof Anesthesiology (Philadelphia), 2000-06, Vol.92 (6), p.1603-1616
issn 0003-3022
1528-1175
language eng
recordid cdi_crossref_primary_10_1097_00000542_200006000_00017
source Journals@Ovid Ovid Autoload; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Algorithms
Anesthetics - pharmacokinetics
Anesthetics - pharmacology
Anesthetics. Neuromuscular blocking agents
Biological and medical sciences
Computer Simulation
Dose-Response Relationship, Drug
Drug Interactions
Humans
Medical sciences
Models, Theoretical
Neuropharmacology
Pharmacology. Drug treatments
title Response surface model for anesthetic drug interactions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T03%3A46%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20surface%20model%20for%20anesthetic%20drug%20interactions&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=MINTO,%20C.%20F&rft.date=2000-06-01&rft.volume=92&rft.issue=6&rft.spage=1603&rft.epage=1616&rft.pages=1603-1616&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/00000542-200006000-00017&rft_dat=%3Cpubmed_cross%3E10839909%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10839909&rfr_iscdi=true